Dollar Donation Club
Organization
Apopo
RAPID TUBERCULOSIS DETECTION USING TRAINED SCENT-DETECTION RATS
🛡️ Trust Rating
🧐 Risk Rating
Return On Donation
$1
What is it?
An ultra cost-effective way to detect tuberculosis faster and at scale, using trained scent-detection rats to find cases traditional clinics miss.
Snapshot
The Problem
Tuberculosis infects 10.8 million people a year and kills 1.3 million, striking hardest in overcrowded, low-income communities. In Dar es Salaam, thousands of cases go undiagnosed each year because clinics rely on slow, outdated testing methods. Undetected TB spreads rapidly—one untreated person can infect 10–15 others—keeping families in a cycle of illness and poverty.
The Solution
APOPO’s trained HeroRATs screen TB samples rapidly and at high volume, identifying cases that clinics miss. Rats can check 100 samples in 10–20 minutes—a task that would take a lab technologist four days. Faster detection means earlier treatment, reduced suffering, and dramatically fewer new infections across the city.
Impact to Date
• 33,767 additional TB cases detected
• 1,023,468 samples screened
• 338,946 potential infections prevented, based on reduced transmission
• 48% average increase in clinic detection rates
Location of Impact
Tanzania
Impact Per $1
Every $1 screens one TB sample, accelerating diagnosis and helping stop the spread of a deadly disease.
Proof of Impact
APOPO shares monthly data on samples screened, samples flagged, and confirmed TB cases. Results currently come from validated tracking sheets, with plans to shift to real-time ArcGIS dashboards within a year.
Time to Realize Impact
Donations are deployed within 1–3 days, because sample screening happens year-round. Impact is immediate.
Fund Usage
100% of funds support TB detection through HeroRAT screening.
Future phases may allocate 50% to screening and 50% to training new rats.
Will it actually make a difference?
Yes. Faster screening finds infectious patients sooner, supports Tanzania’s National TB Program, and reduces the number of undetected cases. Every detected case treated can prevent 10–15 future infections, protecting families and reducing the city’s TB burden.
How is the donation used?
Your donation increases the number of TB samples screened. Rats screen 150–210 samples per day across 90 clinics, turning slow lab processes into rapid, life-saving diagnostics.
DDC's Favorites
Exceptionally clear and measurable impact model (each dollar screens a TB sample).
Strong alignment between mission, science, and on-the-ground execution.
Proven scalability with long-term public health leverage through national TB programs.
Key Drawbacks
Impact relies on sustained funding and continued clinic partnerships.
Addresses detection gaps but does not alone resolve broader TB prevention and health-system constraints.
Fund Usage
100% of funds support TB detection through HeroRAT screening.
Future phases may allocate 50% to screening and 50% to training new rats.
The Context
Tuberculosis (TB) remains one of the world’s deadliest infectious diseases despite effective treatment existing for decades. In 2023 an estimated 10.8 million people fell ill with TB globally, equivalent to about 134 new cases per 100,000 population, and the disease continues to cause a heavy toll on health systems and communities worldwide. Most new TB cases occur in the WHO regions of South-East Asia (45%) and Africa (24%), with millions of lives lost each year if TB is not diagnosed and treated promptly. Tanzania, in East Africa, is among the 30 high-TB burden countries identified by the WHO, meaning it contributes substantially to global TB morbidity and requires intensified control.
According to recent national data aligned with WHO reporting:
The TB incidence rate in Tanzania has declined from 306 cases per 100,000 population in 2015 to 183 per 100,000 in 2023, representing a 40% reduction in incidence over eight.
TB mortality has fallen sharply, with annual TB deaths dropping from approximately 58,000 in 2015 to around 18,400 in 2023 for both HIV-positive and HIV-negative.
Case detection and treatment have improved: in 2023, Tanzania reported a 96% treatment success rate among notified TB cases, exceeding national and WHO targets of > 90%.
In 2021, WHO estimates suggested Tanzania had about 133,000 new TB cases, of which roughly 87,400 were notified to health authorities, highlighting persistent gaps in case.
Despite these gains, Tanzania—and many comparable countries—must continue strengthening TB prevention, diagnosis, and treatment to reach global elimination goals. Barriers such as undiagnosed cases, HIV co-infection, and resource limitations threaten sustained progress.
Individual Questions
100% of contributions go to the Dollar Donation Club Fund, a wholly owned subsidiary of Legacy Global Foundation Inc, a public 501(c)3 charitable organization.
© Dollar Donation Club 2026